Frontlight ResearchEarly access
Taking people in ItalyPhase 2
Long-term study of IMVT-1402 in adults with Graves' disease
Tests IMVT-1402 over a longer period in adults with Graves' disease.
Key facts
- Who runs it
- Immunovant Sciences GmbH
- Where
- Acquaviva delle Fonti, Bergamo, Bologna, Cagliari, Cuneo, Genoa, Leghorn, Milan, Naples, Palermo, Pavia, Perugia, Pieve Emanuele, Pisa, Rome, Siena, Turin, Udine, and Varese, ItalySee the 27 sitesAlso in 10 other countries, 76 sites
- Trial code
- Registry title
- A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 128 people, planned
- Started
- 11 Jun 2026
- Expected to end
- 30 Mar 2030
- Type of study
- Interventional
- Record updated
- 16 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Graves' disease who completed Study IMVT-1402-2502 or Study IMVT-1402-2503. It follows how well IMVT-1402 works over the long term.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Graves' disease (an overactive thyroid caused by the immune system)
- Earlier treatment
- People must have completed Study IMVT-1402-2502 or Study IMVT-1402-2503.
Main reasons for not taking part
- Stopped the study drug for good during the treatment period of the earlier study
- Met the stopping rules of the earlier study at any time while taking part in it
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Participants who completed Study IMVT-1402-2502 or Study IMVT-1402-2503
Who cannot take part
- Have permanently discontinued IMP during the treatment period in the feeder study or have met study stopping criteria at any point up until the end of participation in the feeder study
This trial is currently available in Italy.
Also in 10 other countries, 76 sites
- Ente Ecclesiastico ospedale generale Regionale MiulliAcquaviva delle Fonti, ItalyTaking people
- Azienda Socio Sanitaria Territoriale Papa Giovanni XXIIIBergamo, ItalyTaking people
- Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere ScientificoBologna, ItalyTaking people
- Azienda Ospedaliero - Universitaria di CagliariCagliari, ItalyTaking people
- Azienda Ospedaliera Santa Croce E CarleCuneo, ItalyTaking people
- IRCCS Azienda Ospedaliera MetropolitanaGenoa, ItalyTaking people
- Azienda Unita' Sanitaria Locale Toscana Nord OvestLeghorn, ItalyTaking people
- ASST Grande Ospedale Metropolitano NiguardaMilan, ItalyTaking people
- Fondazione IRCCS Cà Granda Ospedale Maggiore PoliclinicoMilan, ItalyTaking people
- Istituto Auxologico ItalianoMilan, ItalyTaking people
- Ospedale San Raffaele S.r.l.Milan, ItalyTaking people
- Azienda Ospedaliera di Rilievo Nazionale Antonio CardarelliNaples, ItalyTaking people
- Azienda Ospedaliera Universitaria Federico II Di NapoliNaples, ItalyTaking people
- Azienda Ospedaliera Universitaria Policlinico Paolo GiacconePalermo, ItalyTaking people
- Istituti Clinici Scientifici Maugeri S.p.A. Societa' Benefit In Forma Abbreviata Istituti Clinici Scientifici Maugeri S.p.A. Sb O Anche Ics Maugeri S.p.A. Sb O Maugeri S.p.A. SbPavia, ItalyTaking people
- Hospital Santa Maria Della MisericordiaPerugia, ItalyTaking people
- Universita HumanitasPieve Emanuele, ItalyTaking people
- Azienda Ospedaliero Universitaria PisanaPisa, ItalyTaking people
- Azienda Ospedaliero-Universitaria Policlinico Umberto IRome, ItalyTaking people
- Azienda Ospedaliero-Universitaria Sant AndreRome, ItalyTaking people
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSRome, ItalyTaking people
- Fondazione Policlinico Universitario Campus Bio-medico In Forma A Bbreviata FonRome, ItalyTaking people
- Azienda Ospedaliero Universitaria SeneseSiena, ItalyTaking people
- Azienda Ospedaliera Ordine Mauriziano di TorinoTurin, ItalyTaking people
- Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di TorinoTurin, ItalyTaking people
- Azienda Sanitaria Universitaria Friuli CentraleUdine, ItalyTaking people
- Azienda Ospedaliera Ospedale Di Circolo E Fondazione MacchiVarese, ItalyTaking people
About the trial
What the trial wants to find out
To evaluate the efficacy of IMVT-1402 as assessed by maintenance of euthyroidism, off ATD, and off IMVT-1402 for 52 weeks in Group A Participants
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- A Long-Term Extension Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Patients With Graves' Disease
- Plain-language title
- Long-term study of IMVT-1402 in adults with Graves' diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 17 November 2026.
- Record updated
- 16 November 2026